Based in Winston-Salem, North Carolina, Charter Medical designs and manufactures specialty single-use products used in blood management, blood filtration and biopharmaceutical applications.
“The divestiture of Charter Medical is clearly aligned with our strategy to focus our resources on our core businesses in the Thermal/Acoustical and the Filtration and Engineered Materials segments,” said Lydall president and CEO Dale Barnhart.